- Home
- WRB vs DXCM Comparison
WRB vs DXCM Comparison
Compare WRB & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WRB | DXCM |
|---|---|---|
| Founded | 1967 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.5B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | WRB | DXCM |
|---|---|---|
| Price | $67.02 | $72.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 22 |
| Target Price | $70.64 | ★ $86.41 |
| AVG Volume (30 Days) | 2.4M | ★ 5.1M |
| Earning Date | 01-26-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | ★ 22.08 | 7.75 |
| EPS | ★ 4.76 | 1.80 |
| Revenue | ★ $14,654,011,000.00 | $4,515,900,000.00 |
| Revenue This Year | $9.26 | $17.41 |
| Revenue Next Year | $5.37 | $12.73 |
| P/E Ratio | ★ $14.09 | $40.55 |
| Revenue Growth | 11.08 | ★ 14.21 |
| 52 Week Low | $56.86 | $54.11 |
| 52 Week High | $78.96 | $93.25 |
Technical Indicators
Market Signals| Indicator | WRB | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 64.56 |
| Support Level | $66.50 | $68.54 |
| Resistance Level | $69.78 | $75.98 |
| Average True Range (ATR) | 1.55 | 2.80 |
| MACD | -0.09 | 0.33 |
| Stochastic Oscillator | 11.35 | 71.02 |
Price Performance
Historical ComparisonAbout WRB W.R. Berkley Corporation
W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.